Published in
Taylor & Francis, Expert Review of Hematology, 7(10), p. 583-586
DOI: 10.1080/17474086.2017.1339599
Links
Tools
Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events – is better always good?
Journal article published in 2017 by
Ahmet Emre Eskazan 
,
Deniz Ozmen
,
Deniz Ozmen
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 